Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017986	s-asveabe	— (—)	78	83	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, hospital admissions , main diagnosis only

12.50

43.45

1.1

—

Asthma (only as main-diagnosis)

22.88

40.26

1.1

1.0

—

Asthma (diagnoses ohter than nonallergic)

11.61

39.88

1.1

—

Asthma (only as main-diagnosis), excluding more controls

22.63

39.79

1.1

1.0

—

Asthma (mode)

21.02

36.59

1.1

1.0

—

Asthma

20.64

35.87

1.1

1.0

—

Asthma, excluding more controls

20.54

35.69

1.1

1.0

—

Chronic lower respiratory diseases

9.17

27.46

1.1

1.0

—

Asthma, including avohilmo

8.85

26.45

1.1

—

Asthma, unspecified (mode)

25.69

21.21

1.1

1.0

—

Asthma, unspecified (mode), excluding more controls

25.47

21.11

1.1

1.0

—

Asthma/COPD (KELA code 203)

7.42

17.43

1.1

1.0

—

Asthma-related infections

12.85

16.61

1.0

—

Asthma, hospital admission 2, infections

12.85

16.61

1.0

—

17.73

16.34

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

8.90

11.63

1.0

1.2

—

Obesity related asthma

18.90

11.56

1.0

—

Asthma-related pneumonia

24.92

11.10

1.0

—

Asthma, hospital admissions 3, pneumonia

24.92

11.10

1.0

—

Asthma-related pneumonia or sepsis

24.92

11.10

1.0

—

Abnormalities of breathing

4.36

9.69

1.1

—

Contact with and exposure to communicable diseases

8.23

9.01

1.1

1.0

—

Persons with potential health hazards related to communicable diseases

7.25

8.36

1.1

1.0

—

Chronic sinusitis

8.09

8.05

1.1

—

Sleep apnoea, including avohilmo

3.72

6.83

1.0

1.1

—

Dyspnoea

3.39

6.13

1.1

—

Examination and observation for other reasons

4.12

5.99

1.0

1.2

—

Vasomotor and allergic rhinitis

6.69

5.62

1.0

1.1

—

Allergic rhinitis

6.11

5.32

1.0

—

Allergic asthma (mode)

11.16

4.71

1.0

—

Allergic asthma (mode), excluding more controls

11.16

4.71

1.0

—

Voice disturbances

8.19

4.55

1.0

—

Oral corticosteroids

2.81

4.55

1.0

1.1

—

Other arrhythmias

3.34

4.53

1.1

—

Urticaria

5.79

4.43

1.1

1.0

—

Other and unspecified dermatitis

4.06

4.39

1.0

1.1

—

Urticaria and erythema

5.00

4.31

1.1

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.99

4.18

1.1

1.0

—

Triptan medication for migraine, single purchase ok

2.99

4.18

1.1

1.0

—

Dermatitis

3.26

4.15

1.0

1.1

—

Benign paroxysmal vertigo

10.00

4.01

1.0

—

Triptan medication for migraine, min. 3 purchases

3.02

3.92

1.1

1.0

—

Pollen allergy

5.48

3.92

1.0

—

Vocal cord dysfunction

7.83

3.91

1.1

—

Symptoms and signs involving speech and voice

6.00

3.81

1.0

—

Acute sinusitis

3.10

3.78

1.1

1.0

—

Inflammatory bowel disease treatment related agents

2.50

3.52

1.0

1.1

—

COPD differential diagnosis

5.01

3.50

1.0

—

ILD differential diagnosis

5.01

3.50

1.0

—

Other pulmonary diagnosis

5.01

3.50

1.0

—

Excluding asthma or asthma-COPD overlap

5.01

3.50

1.0

—

Female infertility

4.00

3.30

1.0

—

Psoriasis

8.57

3.26

1.2

1.0

—

Atopic dermatitis

2.84

3.21

1.0

—

Other diseases of upper respiratory tract

2.87

3.09

1.0

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

7.50

3.05

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

3.91

3.04

1.0

—

Persons encountering health services in other circumstances

3.63

3.04

1.2

1.0

—

Covid-19 confirmed case

4.70

2.91

1.0

—

Dermatitis and eczema

2.30

2.82

1.0

1.1

—

Psoriasis vulgaris

8.34

2.75

1.2

1.0

—

Cough

3.82

2.68

1.0

1.1

—

Disorders of vestibular function (Vertigo)

4.10

2.61

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

4.67

2.59

1.0

1.1

—

Other heart diseases, wide

2.30

2.58

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.27

2.58

1.1

—

Visual disturbances

3.60

2.57

1.1

1.0

—

Subjective visual disturbances

5.46

2.54

1.2

1.0

—

Cardiac arrhythmias

2.53

2.50

1.0

—

Injuries to the neck

4.38

2.47

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.67

2.43

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

5.00

2.40

1.0

—

DVT of lower extremities and pulmonary embolism

4.98

2.39

1.0

1.1

—

Other disorders of breast

6.25

2.37

1.0

—

Pulmonary heart disease

6.25

2.37

1.0

—

Pulmonary embolism

6.25

2.37

1.0

—

Papulosquamous disorders

4.12

2.36

1.1

—

Peritonsillar abscess

5.56

2.21

1.0

—

Bacterial pneumonia (organism specified)

4.53

2.20

1.2

1.1

—

Sleep apnoea

2.29

2.20

1.0

1.1

—

Allergic conjunctivitis

2.51

2.18

1.0

—

Conjunctivitis

2.28

2.16

1.0

—

Visual disturbances and blindness

3.00

2.14

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

2.24

2.11

1.0

1.1

—

Pacemaker

5.16

2.09

1.2

1.1

—

Spondylosis

2.79

2.08

1.2

1.1

—

Abnormal findings on diagnostic imaging of lung

4.06

2.04

1.5

1.1

—

Scabies, including avohilmo

4.00

2.04

1.2

1.0

—

Deviated nasal septum

4.00

2.03

1.0

1.3

—

Lumbar disc prolapse

2.47

2.00

1.1

—

Venous thromboembolism

3.08

2.00

1.1

—

Headache

2.33

1.97

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

3.79

1.89

1.5

1.1

—

Pediculosis, acariasis and other infestations, including avohilmo

3.53

1.83

1.2

1.0

—

Other and unspecified urticaria

4.17

1.82

1.0

—

Meniscus derangement

2.71

1.82

1.0

1.1

—

Chronic diseases of tonsils and adenoids

2.48

1.79

1.0

1.1

—

Presence of other functional implants

3.19

1.79

1.0

1.2

—

Abnormalities of heart beat

3.42

1.78

1.0

1.1

—

Postpartum care and examination

4.48

1.78

1.0

—

Diseases of inner ear

2.73

1.76

1.0

1.1

—

Internal derangement of knee

2.89

1.70

1.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.39

1.68

1.0

—

Fever of other and unknown origin

2.55

1.68

1.0

1.1

—

ILD medications

1.94

1.65

1.1

—

Valvular heart disease excluding rheumatic fever

3.29

1.65

1.0

1.2

—

Non-rheumatic valve diseases

3.29

1.65

1.0

1.2

—

First line medication for Crohn's disease

1.94

1.65

1.1

—

Disorders of conjunctiva

2.00

1.62

1.0

1.1

—

Maternal care for other conditions predominantly related to pregnancy

2.73

1.60

1.0

—

Other obstetric conditions, not elsewhere classified

2.31

1.58

1.0

—

Influenza and pneumonia

1.88

1.58

1.1

—

Herpesviral [herpes simplex] infections, including avohilmo

3.00

1.58

1.0

—

Other and unspecified effects of external causes

3.00

1.58

1.0

—

Other acute lower respiratory infections

2.46

1.55

1.0

—

Fracture of lower leg, including ankle

0.00

1.52

0.0

1.1

—

Migraine with aura and triptan purchases

3.33

1.52

1.0

—

Car occupant injured in other and unspecified transport accidents

3.33

1.52

1.0

—

Superficial injury of lower leg

3.33

1.52

1.0

—

Pain, not elsewhere classified

3.33

1.52

1.0

—

Bacterial pneumoniae

3.38

1.51

1.2

1.1

—

Coxarthrosis, primary

2.93

1.51

1.0

1.2

—

Anaemias

2.96

1.47

1.0

—

Pregnancy examination and test

3.44

1.46

1.0

—

Bronchitis

1.85

1.44

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

2.49

1.44

1.0

—

Other benign neoplasms of skin

3.13

1.44

1.2

1.0

—

Diseases of the respiratory system

3.01

1.43

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.47

1.43

1.0

—

Hypothyroidism, strict autoimmune

2.03

1.42

1.0

—

Coxarthrosis, primary, with hip surgery

3.09

1.41

1.0

1.2

—

Glaucoma

3.03

1.37

1.0

1.1

—

Other and unspecified iron deficiency

2.94

1.35

1.0

—

Dentofacial anomalies [including malocclusion]

1.92

1.29

1.0

—

Diseases of salivary glands

2.78

1.28

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.33

1.28

1.0

—

Codes for special purposes

2.33

1.28

1.0

—

Fall on same level involving ice and snow

2.04

1.26

1.2

1.1

—

Hypothyroidism and >3 levothyroxin purchases

2.59

1.25

1.0

—

Hypothyroidism, levothyroxine purchases

2.59

1.25

1.0

—

Hypothyroidism (congenital or acquired)

2.58

1.25

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1.77

1.22

1.1

—

Pain in throat and chest

1.97

1.21

1.1

—

Other reaction to severe stress, and adjustment disorders

2.16

1.21

1.1

1.0

—

Exposure to unspecified factor

1.75

1.20

1.1

—

Other joint disorders

1.87

1.20

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.74

1.17

1.1

—

1.81

1.16

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.92

1.16

1.0

—

All pneumoniae

1.73

1.15

1.1

—

Pre-eclampsia or eclampsia

2.50

1.15

1.0

—

Mouth breathing

2.50

1.15

1.2

—

Hallux valgus (acquired)

2.55

1.13

1.0

—

False labour

2.07

1.12

1.0

—

Iron deficiency anaemia

2.45

1.12

1.0

—

Acute bronchitis

2.45

1.12

1.0

—

1.85

1.12

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.85

1.12

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.33

1.12

1.1

1.0

—

Recurrent or chronic depression

2.31

1.11

1.0

—

Pain in joint

2.05

1.11

1.1

1.0

—

Arthropathies

1.81

1.10

1.0

1.1

—

Other menopausal disorders

2.53

1.08

1.0

—

Cardiovascular diseases

1.87

1.05

1.0

—

Spondylopathies

1.91

1.04

1.3

1.1

—

Syncope and collapse

2.32

1.04

1.0

1.2

—

Missing teeth due to accident, extraction or parodontitis

2.08

1.03

1.0

1.2

—

Inflammatory diseases of female pelvic organs

1.82

1.03

1.0

—

Migraine

1.94

1.03

1.0

—

Other headache syndromes

2.05

1.02

1.0

—

Other soft tissue disorders, not elsewhere classified

1.71

1.01

1.1

—

Cystitis

1.73

1.01

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.89

1.00

1.2

1.1

—

Insomnia

1.71

0.99

1.1

—

Migraine with aura

2.17

0.98

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.66

0.97

1.1

—

Disorders of breast

1.76

0.93

1.0

—

Pre-eclampsia or poor fetal growth

1.88

0.93

1.0

—

Chronic periodontitis, including avohilmo

0.48

0.92

1.0

1.1

—

Coxarthrosis

2.15

0.91

1.0

1.2

—

Other intervertebral disc disorders

1.74

0.89

1.1

1.0

—

Sensorineural hearing loss

1.90

0.88

1.4

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.68

0.88

1.0

1.1

—

Concussion

1.88

0.88

1.0

1.1

—

General symptoms and signs

1.63

0.87

1.0

1.1

—

Hypothyroidism, other/unspecified

1.67

0.87

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.86

0.87

1.1

—

Transport accidents

1.85

0.87

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.64

0.86

1.1

—

Medical treatment for female infertility

1.98

0.86

1.0

—

Gonarthrosis

1.81

0.84

1.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.97

0.84

1.0

1.2

—

Pneumonia, organism unspecified

1.65

0.84

1.1

—

Diabetic retinopathy, excluding more controls

0.00

0.83

0.0

1.1

—

Complications of procedures, not elsewhere classified

1.67

0.82

1.1

—

Gastro-oesophageal reflux disease

1.76

0.81

1.0

1.1

—

Falls/tendency to fall

1.57

0.81

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.64

0.81

1.0

1.1

—

Infections of the skin and subcutaneous tissue

1.71

0.81

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.81

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.85

0.80

1.0

—

Antihypertensive medication - note that there are other indications

1.69

0.80

1.0

1.1

—

Maternal care for other known or suspected fetal problems

1.88

0.80

1.0

—

Parasetamol

1.74

0.79

1.0

1.1

—

Acne, including avohilmo

0.00

0.79

0.0

1.0

—

Unspecified mental disorder

0.00

0.77

0.0

1.0

—

Any mental disorder

0.54

0.76

1.0

1.1

—

Primary gonarthrosis, bilateral

2.20

0.76

1.0

1.2

—

Conductive and sensorineural hearing loss

1.71

0.76

1.3

1.1

—

Disorders of vitreous body

2.16

0.76

1.0

1.1

—

Disorders of vitreous body and globe

2.15

0.75

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.70

0.75

1.0

—

Codeine or tramadol medication

1.52

0.74

1.1

1.0

—

Nutritional anaemias

2.07

0.74

1.0

—

Other diseases of urinary system

1.57

0.74

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.79

0.72

1.4

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.79

0.72

1.0

1.1

—

Low back pain

1.65

0.72

1.2

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.64

0.71

1.0

1.1

—

Dermatophytosis, including avohilmo

1.66

0.71

1.1

—

Neurological diseases

1.63

0.71

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.56

0.70

1.0

1.1

—

Pain in limb

1.59

0.68

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.60

0.65

1.0

1.1

—

Disorders of the thyroid gland

1.53

0.65

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

0.56

0.65

1.2

1.1

—

Any reimbursement code in KELA

1.67

0.64

1.0

—

All kidney diseases

0.57

0.63

1.2

1.1

—

Other specific joint derangements/joint disorders

1.64

0.63

1.1

—

Disorders of synovium and tendon

1.65

0.62

1.0

1.1

—

Other heart diseases

1.62

0.62

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.51

0.62

1.0

1.1

—

Atopic dermatitis, strict definition

1.69

0.62

1.0

—

Other functional intestinal disorders

1.68

0.62

1.0

—

Haemorrhage in early pregnancy

1.67

0.61

1.0

—

Noninfective enteritis and colitis

1.66

0.61

1.0

—

Intracranial trauma

1.59

0.61

1.0

1.1

—

Unspecified haematuria

0.00

0.61

0.0

1.2

—

Nonsuppurative otitis media

0.00

0.61

0.0

1.0

—

Schizophrenia or delusion, excluding more controls

0.00

0.60

0.0

1.1

—

Medicines for HER+ breast cancer

0.00

0.60

0.0

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.60

0.0

1.2

—

Carpal tunnel syndrome

1.54

0.59

1.0

1.1

—

Malignant neoplasm of breast, HER-positive

0.00

0.59

0.0

1.0

—

Pregnancy hypertension

1.52

0.58

1.0

—

Episodal and paroxysmal disorders

1.48

0.58

1.0

1.1

—

Varicose veins

1.74

0.58

1.2

1.0

—

Kela-code for severe mental illness

0.00

0.58

0.0

1.0

—

Spontaneous abortion

1.49

0.57

1.0

—

Inguinal hernia

1.66

0.56

1.2

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.45

0.56

1.0

1.1

—

Excessive earwax

1.65

0.56

1.2

1.1

—

Sciatica+with lumbago

1.61

0.55

1.0

1.1

—

Intracranial injury

1.60

0.55

1.0

1.1

—

Sleep disorders (combined)

1.48

0.54

1.1

—

Tonsillectomy and adenotomy

1.49

0.54

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.48

0.54

1.0

1.1

—

Postpartum hemorraghe, all women as controls

1.58

0.54

1.0

—

Diseases of the ear and mastoid process

1.41

0.53

1.2

1.0

—

Diseases of the skin and subcutaneous tissue

1.53

0.53

1.0

1.1

—

Codeine

1.46

0.53

1.1

1.0

—

Periodontitis

0.59

0.53

1.0

1.1

—

Postpartum haemorrhage

1.55

0.53

1.0

—

Disorders of lens

1.55

0.53

1.0

1.2

—

Complications of medical and surgical care

1.44

0.52

1.0

1.1

—

Excessive attrition of teeth

1.41

0.51

1.2

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.60

0.50

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.42

0.49

1.1

—

Tramadol

1.50

0.47

1.1

—

Acute upper respiratory infections

1.44

0.47

1.0

1.1

—

Obesity due to excess calories

1.46

0.46

1.0

—

Polyarthropathies

1.45

0.46

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

1.44

0.46

1.0

—

Sleep disorders

1.42

0.46

1.1

—

Psychiatric diseases

0.64

0.44

1.2

1.1

—

Senile cataract

1.69

0.44

1.0

1.3

—

Hernia

1.43

0.43

1.1

—

Malaise and fatigue

1.64

0.43

1.0

1.1

—

Complications predominantly related to the puerperium

1.61

0.43

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.37

0.43

1.1

—

Other disorders of veins

1.59

0.42

1.0

—

Injuries to the elbow and forearm

1.40

0.42

1.0

1.1

—

Other disorders of ear

1.42

0.42

1.3

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.42

0.0

1.1

—

Heart failure and coronary heart disease

0.00

0.42

0.0

1.3

—

Disorders of thyroid, IBD co-morbidities

0.00

0.42

0.0

1.0

—

Endometriosis

1.53

0.41

1.0

—

Oxycodone

0.00

0.41

0.0

1.2

—

Mycoses, including avohilmo

1.38

0.41

1.1

—

Septicaemia

0.00

0.41

0.0

1.1

—

Inflammatory bowel disease, strict (require KELA)

0.00

0.41

0.0

1.0

—

IBD patients in KELA-register

0.00

0.41

0.0

1.0

—

Zoster [herpes zoster], including avohilmo

1.51

0.41

1.0

1.1

—

Bipolar affective disorders

0.00

0.41

0.0

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

0.68

0.41

1.0

1.1

—

Fracture of forearm

1.50

0.41

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

0.00

0.40

0.0

1.0

—

Dental pulpitis, including avohilmo

1.36

0.40

1.2

1.0

—

Hyperlipidaemia, other/unspecified

0.00

0.40

0.0

1.3

—

Other bacterial diseases, including avohilmo

0.65

0.40

1.0

1.1

—

Open wound of head

1.47

0.40

1.0

1.2

—

Schizophrenia or delusion

0.00

0.39

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.39

0.0

1.0

—

Dorsalgia

1.38

0.39

1.2

1.0

—

Gonarthrosis,primary

1.36

0.39

1.0

1.1

—

Caries of enamel

1.35

0.38

1.1

—

Persons encountering health services for specific procedures and health care

0.68

0.38

1.1

—

Solid cancers

0.62

0.37

1.2

1.0

—

Other inflammation of eyelid, including avohilmo

1.36

0.34

1.2

1.0

—

Postpartum hemorraghe, parous women as controls

1.36

0.34

1.0

—

Neurotic, stress-related and somatoform disorders

1.33

0.34

1.1

1.0

—

Disorders of skin appendages

1.33

0.33

1.0

—

Fall on same level

1.29

0.33

1.1

—

Finngen Rheumatological endpoints

1.32

0.33

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.40

0.32

1.0

1.2

—

Certain infectious and parasitic diseases

0.70

0.32

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

0.71

0.32

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.36

0.32

1.0

1.2

—

Arthrosis

1.37

0.32

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.70

0.31

1.1

—

Diseases of oesophagus, stomach and duodenum

1.30

0.31

1.0

1.1

—

Hypertensive diseases (excluding secondary)

1.31

0.31

1.0

1.1

—

Anxiety disorders

1.31

0.30

1.1

—

Autoimmune diseases

1.29

0.29

1.1

—

Benign neoplasms

1.31

0.29

1.0

1.1

—

Cholecystectomy

1.24

0.29

1.1

1.0

—

Depression

1.29

0.28

1.0

1.1

—

Nerve, nerve root and plexus disorders

1.28

0.28

1.0

1.1

—

Leiomyoma of uterus

1.25

0.28

1.0

—

Shoulder lesions

1.23

0.27

1.3

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.25

0.27

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

0.68

0.27

1.2

1.1

—

Dizziness and giddiness

1.20

0.26

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.28

0.26

1.1

—

Constipation

1.24

0.26

1.0

1.1

—

Other external causes of accidental injury

1.22

0.26

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

1.27

0.25

1.1

—

Solid cancers, including Hilmo

0.73

0.25

1.2

1.0

—

Noninflammatory disorders of female genital tract

1.32

0.24

1.0

—

Autoimmune diseases related-to ILD

1.28

0.24

1.2

1.0

—

Gingivitis and periodontal diseases

0.75

0.23

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.75

0.23

1.0

1.1

—

Benzodiazepine use

1.25

0.22

1.2

1.0

—

Diabetes, varying definitions

1.23

0.22

1.1

—

Diabetes mellitus

1.23

0.22

1.1

—

Fenamates

0.00

0.22

0.0

1.0

—

Mood [affective] disorders

1.24

0.21

1.0

1.1

—

Malignant neoplasm of digestive organs

0.00

0.21

0.0

1.0

—

Hypertensive Heart Disease

0.00

0.21

0.0

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

1.27

0.21

1.0

—

Gout

0.00

0.21

0.0

1.3

—

Malignant neoplasm of digestive organs, including Hilmo

0.00

0.21

0.0

1.0

—

Mood disorders

1.24

0.21

1.0

1.1

—

Congenital malformations of genital organs

0.00

0.21

0.0

1.0

—

Acne

0.00

0.21

0.0

1.0

—

Eating disorder

0.00

0.21

0.0

1.0

—

Diabetic nephropathy, excluding more controls

0.00

0.21

0.0

1.1

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

0.21

0.0

1.0

—

Adenomyosis (Endometriosis of uterus)

0.00

0.21

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.21

0.0

1.0

—

Other viral diseases, not elsewhere classified

0.00

0.21

0.0

1.0

—

Substance use, excluding alcohol

0.00

0.21

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

1.3

—

Alcohol dependence

0.00

0.21

0.0

1.1

—

Gout, FINNGEN

0.00

0.21

0.0

1.3

—

Glucosamine medication

0.00

0.21

0.0

1.0

—

Reimbursement for rheumatic diseases

1.18

0.21

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

1.25

0.21

1.0

1.1

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.0

—

Eating disorders

0.00

0.21

0.0

1.0

—

L02BG Aromatase inhibitors

0.00

0.21

0.0

1.0

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

1.1

—

Hypertensive heart and/or renal disease

0.00

0.21

0.0

1.2

—

Tumor necrosis factor alpha inhibitors

0.00

0.21

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.21

0.0

1.0

—

Stomatitis and related lesions

0.00

0.21

0.0

1.0

—

Tooth eruption problems

0.00

0.20

0.0

1.0

—

Other anxiety disorders

1.28

0.20

1.0

—

Other septicaemia

0.00

0.20

0.0

1.1

—

Biological medication for rheuma

0.00

0.20

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.24

0.20

1.1

—

Rotator cuff syndrome

1.21

0.20

1.3

1.1

—

Soft tissue disorders

1.23

0.19

1.0

1.1

—

Other dorsopathies, not elsewhere classified

1.24

0.19

1.1

1.0

—

Medical abortion

0.73

0.17

1.0

—

Complications of labour and delivery

0.71

0.17

1.0

—

Artificial joint operation, meniscal resection

0.71

0.17

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.74

0.17

1.0

—

Selective serotonin reuptake inhibitors

1.22

0.16

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

0.71

0.16

1.0

—

Pregnancy with abortive outcome

1.13

0.16

1.0

—

Other nutritional deficiencies

1.16

0.16

1.0

1.1

—

Artrosis, including avohilmo

1.12

0.16

1.0

1.1

—

Neoplasms

1.18

0.16

1.0

—

Malignant neoplasm

0.75

0.16

1.2

1.0

—

Malignant neoplasm

0.75

0.16

1.2

1.0

—

Abdominal and pelvic pain

1.16

0.16

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.16

0.16

1.1

—

Disorders of eyelid, lacrimal system and orbit

0.76

0.16

1.5

1.0

—

COPD/asthma/ILD related infections

1.22

0.15

1.0

1.1

—

COPD/asthma related infections

1.22

0.15

1.0

1.1

—

Exposure to other specified factors

1.14

0.15

1.1

—

Malignant neoplasm, including Hilmo

0.81

0.15

1.1

1.0

—

Hypertension, essential

0.78

0.15

1.0

1.1

—

Any event in cancer register

0.83

0.14

1.1

1.0

—

Biguanides

1.19

0.13

1.1

—

Chronic apical periodontitis

0.81

0.13

1.0

—

Opioids

1.18

0.13

1.0

—

Diseases of the eye and adnexa

1.19

0.12

1.0

—

Mood disorders, excluding more controls

1.17

0.12

1.0

1.1

—

Other diseases of intestines

0.86

0.11

1.0

1.1

—

Lower back pain or/and sciatica

1.15

0.10

1.2

1.0

—

Labour and delivery complicated by fetal stress [distress]

1.16

0.10

1.0

—

Anxiety disorders, excluding more controls

1.16

0.10

1.1

—

L04AX Other immunosuppressants

1.14

0.10

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.09

0.09

1.0

1.1

—

Diabetes mellitus in pregnancy

1.06

0.09

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.05

0.09

1.0

—

Second line medication for Crohn's disease

1.04

0.09

1.0

1.1

—

Type 2 diabetes, definitions combined

1.14

0.09

1.1

—

Diverticular disease of intestine

1.10

0.09

1.2

1.1

—

Certain infectious and parasitic diseases, including avohilmo

1.07

0.09

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.06

0.09

1.2

1.1

—

Other disorders of skin and subcutaneous tissue

1.08

0.08

1.0

1.1

—

Gastrointestinal diseases

1.06

0.08

1.0

—

Irregular menses

1.07

0.08

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.07

0.08

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.06

0.08

1.1

—

Use of hypnotics and sedatives

1.12

0.08

1.1

—

Implicit Sepsis, including avohilmo

1.04

0.08

1.1

—

Obesity

1.03

0.07

1.0

1.1

—

Obesity and other hyperalimentation

1.03

0.07

1.0

1.1

—

Appendicitis, broad definition

0.80

0.07

1.0

1.1

—

Diseases of appendix

0.80

0.07

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

1.04

0.07

1.0

—

Urinary track infection

1.03

0.07

1.0

—

GASTRO-related operations

0.84

0.07

1.0

—

Any gastric operation

0.84

0.07

1.0

—

Injuries to the ankle and foot

1.05

0.07

1.0

1.1

—

Statin medication

0.86

0.07

1.0

1.1

—

Malignant neoplasm, wide definition

0.83

0.07

1.1

1.0

—

Cholelithiasis

0.87

0.07

1.1

—

Cholelithiasis, broad definition with cholecystitis

0.85

0.07

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

0.84

0.07

1.0

1.1

—

Hypertensive diseases

0.87

0.07

1.0

1.1

—

Hypertension

0.87

0.07

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

1.12

0.07

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.12

0.06

1.1

—

Type 2 diabetes

1.10

0.04

1.1

—

Other (not insulin) diabetes medications

1.09

0.04

1.1

—

Dorsopathies

1.10

0.03

1.0

—

Metabolic disorders

1.09

0.03

1.1

—

Diabetes medication

1.02

0.00

1.1

—

Persons encountering health services in other circumstances, wide

0.99

0.00

1.2

1.1

—

Used for control exclusion in common control thyroid runs

0.99

0.00

1.0

1.1

—

Injuries to the wrist and hand

0.99

0.00

1.0

1.1

—

Injuries to the head

0.99

0.00

1.0

1.1

—

Injuries to the knee and lower leg

1.03

0.00

1.0

1.1

—

Other abnormal products of conception

0.96

0.00

1.0

—

Budesonide

0.00

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.0

1.0

—

Benign neoplasm: Sigmoid colon

0.00

0.0

1.0

—

Use of pramipexole

0.00

0.0

1.0

—

Alzheimer disease, including avohilmo

0.00

0.0

1.0

—

Otalgia

0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

Adalimumab

0.00

0.0

1.0

—

Fibroblastic disorders

0.00

0.0

1.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.0

1.0

—

Special screening examination for neoplasms

0.00

0.0

1.2

—

Lichen planus

0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland, including Hilmo

0.00

0.0

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.95

0.00

1.1

—

Schizophrenia

0.00

0.0

1.0

—

Problems related to lifestyle

0.00

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

1.0

—

Sulfonylureas

0.00

-0.00

0.0

1.1

—

Cervical polyps

0.00

-0.00

0.0

1.0

—

Disorders of continuity of bone

0.00

-0.00

0.0

1.0

—

Gestational diabetes (for exclusion)

1.01

-0.00

1.0

—

Gout, unspecified

0.00

-0.00

0.0

1.0

—

Accidents

0.95

-0.00

1.0

1.1

—

Chalazion

0.00

-0.00

0.0

1.0

—

Other gastritis (incl. Duodenitis)

0.00

-0.00

0.0

1.0

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.0

—

External causes of morbidity and mortality

0.94

-0.00

1.0

1.1

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Other diseases of liver

0.00

-0.00

0.0

1.0

—

Plantar fascial fibromatosis

0.00

-0.00

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

1.0

—

Intestinal stricture

0.00

-0.00

0.0

1.0

—

Family history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Any dementia

0.00

-0.00

0.0

1.0

—

Paralytic ileus and intestinal obstruction

0.00

-0.00

0.0

1.0

—

Diseases of middle ear and mastoid

0.95

-0.00

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

1.0

—

Speech therapy

0.00

-0.00

0.0

1.0

—

Acne vulgaris

0.00

-0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.0

—

Ulcer of lower limb, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Pain associated with micturition

0.00

-0.00

0.0

1.0

—

Recurrent aphthous stomatitis , including avohilmo

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.00

-0.00

0.0

1.1

—

Intracerebral haemorrhage

0.00

-0.00

0.0

1.0

—

Coronary revascularization (ANGIO or CABG)

0.98

-0.00

1.0

1.1

—

Other embolism and thrombosis

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

ILD medications: immunosuppressive drugs

1.01

-0.00

1.0

1.1

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Assault

0.00

-0.00

0.0

1.0

—

Other CVD

0.00

-0.00

0.0

1.0

—

Postprocedural disorders of nervous system

0.00

-0.00

0.0

1.0

—

Diabetic nephropathy

0.00

-0.00

0.0

1.1

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck, including Hilmo

0.00

-0.00

0.0

1.0

—

Other diseases of pancreas

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

-0.00

0.0

1.0

—

Spontaneous rupture of synovium and tendon

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

-0.00

0.0

1.0

—

Superficial injury of ankle and foot

0.00

-0.00

0.0

1.0

—

Demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Mucosal proctocolitis

0.00

-0.00

0.0

1.0

—

Deep endometriosis

0.00

-0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome, consortium definition

0.92

-0.00

1.0

—

Glomerular diseases

0.00

-0.00

0.0

1.0

—

Hydronephrosis

0.00

-0.00

0.0

1.0

—

Gout, idiopatic and unspecified

0.00

-0.00

0.0

1.1

—

Continuous positive airway pressure

0.00

-0.00

0.0

1.1

—

Pleural effusion

0.00

-0.00

0.0

1.0

—

Endocrine, nutritional and metabolic diseases

0.94

-0.00

1.0

1.1

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

1.0

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.0

—

Ischemic heart diseases

0.85

-0.00

1.0

1.1

—

Other disorders of urethra and urinary system

0.91

-0.00

1.2

1.0

—

Other noninflammatory disorders of vagina

0.00

-0.00

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.0

—

Mental disorders, not otherwise specified

0.00

-0.00

0.0

1.0

—

Injuries to the shoulder and upper arm

0.87

-0.00

1.3

1.1

—

Cholecystitis

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.0

—

Other diseases of intestine

0.00

-0.00

0.0

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA)

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

All anxiety disorders

0.99

-0.00

1.0

—

Status post-ami

0.00

-0.00

0.0

1.1

—

Any dementia, excluding more controls

0.00

-0.00

0.0

1.0

—

Zoster [herpes zoster]

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

-0.00

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

0.00

-0.00

0.0

1.0

—

Use of anticholinesterases

0.00

-0.00

0.0

1.0

—

Implicit Sepsis

1.00

-0.00

1.2

1.1

—

Non-Hodgkin lymphoma, all, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.0

—

Colorectal cancer

0.00

-0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

1.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Major coronary heart disease event

0.88

-0.00

1.0

1.1

—

Percutaneous Coronary Intervention

0.98

-0.00

1.0

1.1

—

Coronary artery bypass grafting

0.00

-0.00

0.0

1.3

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Spirochaetal infections, other/unspecified

0.00

-0.00

0.0

1.0

—

Sarcoidosis

0.00

-0.00

0.0

1.0

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri

0.00

-0.00

0.0

1.0

—

Later onset COPD

0.00

-0.00

0.0

1.0

—

Other congenital malformations, including avohilmo

0.00

-0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Colorectal cancer, including Hilmo

0.00

-0.00

0.0

1.0

—

Other superficial mycoses, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

-0.00

0.0

1.0

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.0

—

N06DA Anticholinesterases

0.00

-0.00

0.0

1.0

—

Heartburn

0.00

-0.00

0.0

1.0

—

Abnormalities of gait and mobility

0.00

-0.00

0.0

1.0

—

5-aminosalicylic acid

0.00

-0.00

0.0

1.0

—

Social phobias

0.00

-0.00

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

-0.00

0.0

1.0

—

Focal epilepsy

0.00

-0.00

0.0

1.0

—

Focal epilepsy, strict definition

0.00

-0.00

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Alzheimer disease

0.00

-0.00

0.0

1.0

—

Bell's palsy

0.00

-0.00

0.0

1.0

—

Anxiety (asthma-related co-morbidities)

0.97

-0.00

1.0

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

1.0

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.0

—

Enlarged lymph nodes

0.00

-0.00

0.0

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.95

-0.00

1.0

1.1

—

Other obstructed labour

0.00

-0.00

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

-0.00

0.0

1.0

—

Other antidepressants

0.98

-0.00

1.0

1.1

—

Fracture of skull and facial bones

0.00

-0.00

0.0

1.0

—

Colectomy operation

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of urinary organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

-0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Hypo-osmolality and hyponatraemia

0.00

-0.00

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

Osteoporosis

0.00

-0.00

0.0

1.0

—

Intestinal infectious diseases

0.97

-0.00

1.1

—

Impingement syndrome of shoulder

0.00

-0.00

0.0

1.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aspergillus versicolor IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS